| Literature DB >> 31991093 |
Aarti Krishnan1, Joachim Kloehn1, Matteo Lunghi1, Anush Chiappino-Pepe2, Benjamin S Waldman3, Damien Nicolas1, Emmanuel Varesio4, Adrian Hehl5, Sebastian Lourido6, Vassily Hatzimanikatis2, Dominique Soldati-Favre7.
Abstract
To survive and proliferate in diverse host environments with varying nutrient availability, the obligate intracellular parasite Toxoplasma gondii reprograms its metabolism. We have generated and curated a genome-scale metabolic model (iTgo) for the fast-replicating tachyzoite stage, harmonized with experimentally observed phenotypes. To validate the importance of four metabolic pathways predicted by the model, we have performed in-depth in vitro and in vivo phenotyping of mutant parasites including targeted metabolomics and CRISPR-Cas9 fitness screening of all known metabolic genes. This led to unexpected insights into the remarkable flexibility of the parasite, addressing the dependency on biosynthesis or salvage of fatty acids (FAs), purine nucleotides (AMP and GMP), a vitamin (pyridoxal-5P), and a cofactor (heme) in both the acute and latent stages of infection. Taken together, our experimentally validated metabolic network leads to a deeper understanding of the parasite's biology, opening avenues for the development of therapeutic intervention against apicomplexans.Entities:
Keywords: CRISPR-Cas9 screen; Toxoplasma gondii; bradyzoite; fatty acid biosynthesis; heme biosynthesis; metabolic network; metabolism; synthetic lethality; tachyzoite; vitamin B6
Year: 2020 PMID: 31991093 DOI: 10.1016/j.chom.2020.01.002
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023